These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 15242487)
1. Optimal treatment strategy for elderly patients with hepatocellular carcinoma. Dohmen K; Shirahama M; Shigematsu H; Irie K; Ishibashi H J Gastroenterol Hepatol; 2004 Aug; 19(8):859-65. PubMed ID: 15242487 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients. Dohmen K; Shigematsu H; Irie K; Ishibashi H Hepatogastroenterology; 2003; 50(54):2022-7. PubMed ID: 14696457 [TBL] [Abstract][Full Text] [Related]
3. Impact of hepatologists to extend survival of hepatocellular carcinoma patients with cirrhosis: a comparison with non-hepatologists. Dohmen K; Shirahama M; Shigematsu H; Irie K; Ishibashi H Hepatogastroenterology; 2004; 51(56):564-9. PubMed ID: 15086203 [TBL] [Abstract][Full Text] [Related]
4. Trends in clinical characteristics, treatment and prognosis of hepatocellular carcinoma. Dohmen K; Shigematsu H; Irie K; Ishibashi H Hepatogastroenterology; 2003; 50(54):1872-7. PubMed ID: 14696422 [TBL] [Abstract][Full Text] [Related]
5. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population. Chantajitr S; Wilasrusmee C; Lertsitichai P; Phromsopha N J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428 [TBL] [Abstract][Full Text] [Related]
8. [A comparison of patients with hepatocellular carcinoma between a short-term (less than 6 months) survival group and a long-term (over 24 months) survival group after treatment with transcatheter arterial chemoembolization]. Kang IK; Kim SW; Hahn SH; Cho SC; Gham CW; Lee DH Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):189-200. PubMed ID: 12499805 [TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics among patients with hepatocellular carcinoma according to the serum levels of alpha-fetoprotein and des-y-carboxy prothrombin. Dohmen K; Shigematsu H; Irie K; Ishibashi H Hepatogastroenterology; 2003; 50(54):2072-8. PubMed ID: 14696467 [TBL] [Abstract][Full Text] [Related]
10. Usefulness of tumor pressure as a prognostic factor in cases of hepatocellular carcinoma where the diameter of the tumor is 3 cm or less. Ueki T; Sakaguchi S; Miyajima Y; Hatono N; Tohara K; Nakabayashi S; Yao T; Kokawa H; Hirano M; Okumura M Cancer; 2002 Aug; 95(3):596-604. PubMed ID: 12209753 [TBL] [Abstract][Full Text] [Related]
11. Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center. Ueno S; Tanabe G; Nuruki K; Oketani M; Komorizono Y; Hokotate H; Fukukura Y; Baba Y; Imamura Y; Aikou T J Hepatobiliary Pancreat Surg; 2002; 9(4):469-77. PubMed ID: 12483269 [TBL] [Abstract][Full Text] [Related]
12. Hepatic resection for hepatocellular carcinoma in elderly patients. Yeh CN; Lee WC; Jeng LB; Chen MF Hepatogastroenterology; 2004; 51(55):219-23. PubMed ID: 15011868 [TBL] [Abstract][Full Text] [Related]
13. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study. Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197 [TBL] [Abstract][Full Text] [Related]
14. Do young hepatocellular carcinoma patients with relatively good liver function have poorer outcomes than elderly patients? Cho SJ; Yoon JH; Hwang SS; Lee HS J Gastroenterol Hepatol; 2007 Aug; 22(8):1226-31. PubMed ID: 17498220 [TBL] [Abstract][Full Text] [Related]
15. Analysis of the clinicopathological features of hepatocellular carcinoma in elderly patients. Jing-Lin X; Sharma D; Bing-Hui Y; Bo-Heng Z; Zeng-Chen M; Zhi-Quan W; Jia F; Xin ZD; Lun-Xiu Q; Zhao-You X JNMA J Nepal Med Assoc; 2008; 47(171):132-5. PubMed ID: 19079378 [TBL] [Abstract][Full Text] [Related]
16. Clinical and pathologic features of hepatocellular carcinoma in young and older Italian patients. Trevisani F; D'Intino PE; Grazi GL; Caraceni P; Gasbarrini A; Colantoni A; Stefanini GF; Mazziotti A; Gozzetti G; Gasbarrini G; Bernardi M Cancer; 1996 Jun; 77(11):2223-32. PubMed ID: 8635088 [TBL] [Abstract][Full Text] [Related]
17. Changes in the characteristics and survival rate of hepatocellular carcinoma from 1976 to 2000: analysis of 1365 patients in a single institution in Japan. Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Hayashi K; Honda T; Kitabatake S; Kuzuya T; Nonogaki K; Kasugai T; Shimizu J Cancer; 2004 Jun; 100(11):2415-21. PubMed ID: 15160346 [TBL] [Abstract][Full Text] [Related]
18. [Evaluation of prognosis and recurrence of hepatocellular carcinoma treated from 1988 to 2002 at Department of Medicine III, Kyushu University Hospital]. Arimura E; Nakamuta M; Kotoh K; Morizono S; Fukutomi M; Ohta S; Enjoji M; Sakai H; Nawata H Fukuoka Igaku Zasshi; 2004 Aug; 95(8):195-200. PubMed ID: 15552961 [TBL] [Abstract][Full Text] [Related]
19. Clinical features and treatment of hepatocellular carcinoma in eight patients older than eighty years of age. Hazama H; Omagari K; Matsuo I; Masuda J; Ohba K; Sakimura K; Kinoshita H; Isomoto H; Murase K; Kohno S Hepatogastroenterology; 2001; 48(42):1692-6. PubMed ID: 11813602 [TBL] [Abstract][Full Text] [Related]
20. The impact of newer treatment modalities on survival in patients with hepatocellular carcinoma. Taura N; Hamasaki K; Nakao K; Ichikawa T; Nishimura D; Goto T; Fukuta M; Kawashimo H; Fujimoto M; Kusumoto K; Motoyoshi Y; Shibata H; Eguchi K Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1177-83. PubMed ID: 16901768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]